BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2318549)

  • 1. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease.
    Kato T; Yoneda S; Kako T; Koketsu M; Hayano I; Fujinami T
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):123-6. PubMed ID: 2318549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
    Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.
    Tomono Y; Hasegawa J; Seki T; Motegi K; Morishita N
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):536-41. PubMed ID: 3781673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations.
    Taggart DP; Jenkins M; Hooper J; Hadjinikolas L; Kemp M; Hue D; Bennett G
    Ann Thorac Surg; 1996 Mar; 61(3):829-33. PubMed ID: 8619701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
    Bhagavan HN; Chopra RK
    Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K; Horiuchi A; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yonezawa T; Tsubakio T; Kawagoe H; Shinohara Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men.
    Porter DA; Costill DL; Zachwieja JJ; Krzeminski K; Fink WJ; Wagner E; Folkers K
    Int J Sports Med; 1995 Oct; 16(7):421-7. PubMed ID: 8550248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia.
    Hanisch F; Zierz S
    Eur J Med Res; 2003 Nov; 8(11):485-91. PubMed ID: 14644702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidative effect of dietary coenzyme Q10 in human blood plasma.
    Weber C; Sejersgård Jakobsen T; Mortensen SA; Paulsen G; Hølmer G
    Int J Vitam Nutr Res; 1994; 64(4):311-5. PubMed ID: 7883471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome.
    Kumar A; Kaur H; Devi P; Mohan V
    Pharmacol Ther; 2009 Dec; 124(3):259-68. PubMed ID: 19638284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
    Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A
    Biomed Pharmacother; 2005 Jul; 59(6):312-7. PubMed ID: 15932792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activities of coenzyme Q10 and vitamin B6 for immune responses.
    Folkers K; Morita M; McRee J
    Biochem Biophys Res Commun; 1993 May; 193(1):88-92. PubMed ID: 8503942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.
    Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N
    Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
    Liu ZX; Artmann C
    Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic parameters during the 6 months following myocardial infarct].
    Tóth K; Mezey B; Juricskay I; Simor T; Jávor T
    Orv Hetil; 1990 Apr; 131(14):727-30. PubMed ID: 2183141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of coenzyme Q10 in patients with kidney diseases].
    Gazdíková K; Gvozdjáková A; Kucharská J; Spustová V; Braunová Z; Dzúrik R
    Cas Lek Cesk; 2001 May; 140(10):307-10. PubMed ID: 11411060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
    Bacher A; Eggensperger E; Koppensteiner R; Mayer N; Klimscha W
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coenzyme Q10 on salivary secretion.
    Ryo K; Ito A; Takatori R; Tai Y; Arikawa K; Seido T; Yamada T; Shinpo K; Tamaki Y; Fujii K; Yamamoto Y; Saito I
    Clin Biochem; 2011 Jun; 44(8-9):669-74. PubMed ID: 21406193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between hemodynamics and hemorrheology in chronic cor pulmonale].
    Zhao YF
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Feb; 14(1):11-2, 60-1. PubMed ID: 1908749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.